Journal of the National Cancer Institute

Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.

Journal of the National Cancer Institute

Nakamura Y, Ratain MJ, Cox NJ, McLeod HL, Kroetz DL, Flockhart DA

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

Journal of the National Cancer Institute

Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD

Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.

Journal of the National Cancer Institute

Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, Grandis JR

Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.

Journal of the National Cancer Institute

Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, Turley EA, Bissell MJ

Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.

Journal of the National Cancer Institute

Lango MN, Dyer KF, Lui VW, Gooding WE, Gubish C, Siegfried JM, Grandis JR

Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.

Journal of the National Cancer Institute

He Y, Zeng Q, Drenning SD, Melhem MF, Tweardy DJ, Huang L, Grandis JR

Characterization of oral streptococci that activate the dietary glycoside rutin to a mutagen.

Journal of the National Cancer Institute

Shillitoe EJ, Hoover CI, Fisher SJ, Abdel-Salam M, Greenspan JS

Characterization of Sialyltransferase in Noncancerous and Neoplastic Human Liver Tissue2.

Journal of the National Cancer Institute

Holly A. Ingraham, Jack A. Alhadeff